These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27282306)

  • 1. Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma.
    Gill K; Bayart C; Desai R; Golden A; Raimer P; Tamburro J
    Pediatr Dermatol; 2016 Jul; 33(4):e232-4. PubMed ID: 27282306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
    Almebayadh M
    J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.
    Beal BT; Chu MB; Siegfried EC
    Pediatr Dermatol; 2014; 31(6):754-6. PubMed ID: 25424217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of topical beta blockers as treatment for infantile hemangiomas.
    Painter SL; Hildebrand GD
    Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
    Rizvi SA; Yusuf F; Sharma R; Rizvi SW
    Semin Ophthalmol; 2015 Jan; 30(1):62-4. PubMed ID: 24074395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
    Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
    Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH).
    Boos MD; Castelo-Soccio L
    J Am Acad Dermatol; 2016 Mar; 74(3):567-70. PubMed ID: 26892656
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.
    Painter SL; Hildebrand GD
    J AAPOS; 2016 Apr; 20(2):172-174.e1. PubMed ID: 27079600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
    Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
    J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].
    Heimann K; Peschgens T; Merz U; Hoernchen H; Wenzl T
    Ophthalmologe; 2007 Jun; 104(6):505-7. PubMed ID: 17334744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
    Danarti R; Ariwibowo L; Radiono S; Budiyanto A
    Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N; Guo S; Langer P
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical timolol for an iris hemangioma.
    Gummi R; Stahl ED; Marsh JD
    J AAPOS; 2018 Apr; 22(2):156-158. PubMed ID: 29412149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid complete regression of an early infantile hemangioma with topical timolol gel.
    Semkova K; Kazandjieva J
    Int J Dermatol; 2014 Feb; 53(2):241-2. PubMed ID: 24261914
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
    Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
    Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
    Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
    Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
    Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
    Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.